Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review

SET-CAN/NUP214 fusion is a recurrent event most commonly seen in T-cell acute lymphoblastic leukemia (T-ALL). It is related to resistance to glucocorticoids and chemotherapy; however, the reported prognosis of T-ALL with SET-CAN/NUP214 fusion is diverse, and the optimal treatment option remains unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Na, Liu, Zhenghua, Li, Yan, Yan, Xiaojing, Wang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044795/
https://www.ncbi.nlm.nih.gov/pubmed/33869055
http://dx.doi.org/10.3389/fonc.2021.651494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044795/
https://www.ncbi.nlm.nih.gov/pubmed/33869055
http://dx.doi.org/10.3389/fonc.2021.651494

Ejemplares similares